PEG-rhG-GSF Clinical Trials

1 actively recruiting trial

Also known as: Polyethylene glycolylated recombinant human granulocyte stimulating factor

Pipeline

Phase 3: 1

Top Sponsors

The First Affiliated Hospital with Nanjing Medical University1

Indications

Esophageal Squamous Cell Carcinoma1
Cancer1

Other1 trial

Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.